Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Randomized Experiments

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...

Dosage Regimen Designs: Nomograms and Tabulations

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Methods of Medium Optimization

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[One case of external canal neurofibromatosis].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2012

Same author

Retrotransposon long interspersed nucleotide element-1 (LINE-1) is activated during salamander limb regeneration.

Development, growth & differentiation·2012

Same author

Highly shape-selective synthesis of monodispersed fivefold twinned platinum nanodecahedrons and nanoicosahedrons.

Chemistry (Weinheim an der Bergstrasse, Germany)·2012

Same author

Isolation and characterization of primary skeletal muscle satellite cells from rats.

Toxicology mechanisms and methods·2012

Same author

Workplace violence and influencing factors among medical professionals in China.

American journal of industrial medicine·2012

Same author

Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms.

Blood·2012

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Optimum treatment allocation rules under a variance heterogeneity model.

Weng Kee Wong¹, Wei Zhu

¹Department of Biostatistics, School of Public Health, University of California at Los Angeles, 10833 Le Conte Ave., Los Angeles, CA 90095, USA. wkwong@ucla.edu

Statistics in Medicine

|June 20, 2008

Summary

This study introduces new optimal treatment allocation schemes for varying outcome variances. These designs are efficient, robust, and do not require iterative calculations, simplifying trial design.

Related Experiment Videos

Last Updated: Jul 4, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

Biostatistics
Clinical Trial Design
Experimental Design

Background:

Optimal treatment allocation is crucial for efficient clinical trials, especially when outcome variances differ between groups.
Existing optimal designs, like A-optimal designs, often require complex iterative schemes.
Accurate estimation of treatment effects with varying interests necessitates robust allocation strategies.

Purpose of the Study:

To develop novel, non-iterative optimal treatment allocation schemes for situations with heterogeneous outcome variances.
To assess the robustness of these proposed designs against potential mis-specifications in expected variances.
To compare the efficiency of the new schemes against popular allocation methods.

Main Methods:

Derivation of optimal treatment allocation schemes without iterative procedures.
Evaluation of design robustness through sensitivity analyses to variance mis-specification.
Efficiency comparisons using theoretical metrics and simulations.

Main Results:

The proposed optimal designs provide efficient treatment effect estimation with varying objectives.
These designs are robust to mis-specifications in expected variances.
Certain popular allocation schemes demonstrate poor efficiency under specific variance heterogeneity scenarios.

Conclusions:

The developed non-iterative optimal allocation schemes offer a practical and robust approach for clinical trial design with heterogeneous variances.
These methods enhance the efficiency of estimating treatment effects, accommodating unequal interest.
The findings inform the design of trials, including those for rheumatoid arthritis and cancer screening.